Cover Image

Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer

Objectives: We quantitatively characterized the change in temporospatial expression of repressive and stimulatory checkpoints across immune cell populations in the tumor microenvironment in a cohort of high grade serous ovarian carcinomas (HGSOC) using matched samples before and after neoadjuvant pl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rami Vanguri (Author), Jamal Benhamida (Author), Jonathan H. Young (Author), Yanyun Li (Author), Oliver Zivanovic (Author), Dennis Chi (Author), Alexandra Snyder (Author), Travis J. Hollmann (Author), Katherine L. Mager (Author)
Format:	Book
Published:	Elsevier, 2022-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
by: Zibi Marchocki, et al.
Published: (2022)

Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer
by: Julia McAdams, et al.
Published: (2024)

Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatment
by: Chanhee Han, et al.
Published: (2018)

Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation
by: Julie Terzic, et al.
Published: (2020)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
by: Kenneth P. Nephew (Ed.)
Published: (2019)

Proteome profiling of low grade serous ovarian cancer
by: Haniyeh Bashi zadeh fakhar, et al.
Published: (2019)

Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer
by: Jung Mi Byun, et al.
Published: (2023)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
by: Renan Ribeiro e Ribeiro, et al.
Published: (2021)

Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
by: Zheng Feng, et al.
Published: (2023)

Response to trametinib in recurrent low-grade serous ovarian cancer with NRAS mutation: A case report
by: Miriam Champer, et al.
Published: (2019)

Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinoma
by: Tasha Serna-Gallegos, et al.
Published: (2017)

Digital pathology-based study of cell- and tissue-level morphologic features in serous borderline ovarian tumor and high-grade serous ovarian cancer
by: Jun Jiang, et al.
Published: (2021)

Real World Application of Chemotherapy Response Score in High Grade Serous Cancer of the Ovary
by: Federico Ferrari, et al.
Published: (2022)

MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma
by: Lili Zhong, et al.
Published: (2022)

Targeted therapy in high grade serous ovarian Cancer: A literature review
by: Kaitlyn Dinkins, et al.
Published: (2024)

Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma
by: Rosie T. Jiang, et al.
Published: (2017)

Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
by: Lu Zhang, et al.
Published: (2021)

Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
by: A. W. Adamson, et al.
Published: (2023)

Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series
by: Lawrence Kasherman, et al.
Published: (2021)

Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon
by: Reem Abdallah, et al.
Published: (2023)

Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer
by: Michelle Greenman, et al.
Published: (2024)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
by: Huan Wu, et al.
Published: (2019)

Paraneoplastic opsoclonus-myoclonus syndrome as a presentation of high grade serous ovarian cancer
by: Kimberly T. Stewart, et al.
Published: (2019)

Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer
by: Daniela Criscuolo, et al.
Published: (2022)

High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature
by: Yuichiro Hatano, et al.
Published: (2019)

Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1
by: Eric J. Norris, et al.
Published: (2018)

The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer
by: Siddik Sarkar, et al.
Published: (2024)

Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer
by: Shashank Sama, et al.
Published: (2024)

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
by: Huan Wu, et al.
Published: (2020)

Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer
by: Hua Yang, et al.
Published: (2022)

Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer
by: Yan Cai, et al.
Published: (2024)

Clinical outcomes of immunohistochemistry of the p53 Staining pattern in high-grade serous ovarian carcinoma
by: Panarat Orachum, et al.
Published: (2022)

Undiagnosed tubal high-grade serous carcinoma metastatic to synchronous benign ovarian Brenner tumor
by: Abhijit Chougule, et al.
Published: (2018)

Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery
by: Shuqing Li, et al.
Published: (2020)

Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma
by: Saubhagya Kumar Jena, et al.
Published: (2015)

Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan
by: Kuan-Chong Chao, et al.
Published: (2013)

Diagnosis of Ia-Ic stages of serous high-grade ovarian cancerby the lipid profile of blood serum
by: Mariia V. Iurova, et al.
Published: (2021)

Ovarian high-grade serous carcinoma with estrogenic manifestations in a postmenopausal woman: A case report
by: Akihiro Takeda, et al.
Published: (2023)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
by: Se Ik Kim, et al.
Published: (2019)

NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells
by: Cassie Liu, et al.
Published: (2024)